throbber
Trials@uspto. gov
`571-272-7822
`
`Paper 15
`Entered: February 23, 2023
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APPLEINC.,
`Petitioner,
`
`V.
`
`MASIMO CORPORATION,
`Patent Owner.
`
`IPR2022-01466
`Patent 10,687,745 B1
`
`Before JOSIAH C. COCKS, NEIL T. POWELL, and JAMES A. TARTAL,
`Administrative Patent Judges.
`
`TARTAL, Administrative Patent Judge.
`
`DECISION
`Denying Institution of /nter Partes Review
`35 US.C. $314
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`I.
`
`INTRODUCTION
`
`Apple Inc. (“Petitioner”)! filed a Corrected Petition pursuantto
`
`35 U.S.C. §§ 311-319 requesting an interpartes review of claims 2-6, 8,
`
`10-14, 17, 19, and 21—26 (“Challenged Claims’’) of U.S. Patent
`
`No. 10,687,745 B1 (Ex. 1001, “the °745 patent”). Paper 10 (“Pet.”).
`
`Petitioner concurrently filed another petition in another proceeding
`
`requesting interpartes review of the Challenged Claims on different
`
`grounds. Apple, Inc. v. Masimo Corporation, IP R2022-01465, Paper 10
`
`(PTAB October7, 2022) (“the ’1465 Petition’’). Petitioneralso filed a
`
`Notice Ranking Petitions requesting that we consider whetherto institute
`
`review based on the ’1465 Petition prior to considering the Petition in this
`
`proceeding. Paper 2 (“NRP”’). InIPR2022-01465 wegranted the ’1465
`
`Petition and instituted an interpartes review of claims 1-6, 8, 10-14, 17, 19,
`
`and 21—26 of the ’745 patent. IPR2022-01291, Paper 15 (PTAB February 1,
`
`2023).
`
`Masimo Corporation (“Patent Owner’’)’ filed a Preliminary Response
`
`to the Petition. Paper 11. Patent Owneralso filed a Response to the NRP of
`
`Petitioner. Paper 12.
`
`For the reasons provided below, and based on the circumstances
`
`present here, we find a secondpetition challenging the sameclaims ofthe
`
`samepatent is not warranted and exercise discretion under 35 U.S.C.
`
`§ 314(a) to deny institution of an interpartes review in this proceeding.
`
`' Petitioner identifies no additional real parties in interest. Pet. 70.
`* Patent Owneridentifies no additional real parties in interest. Paper 5, 2.
`
`2
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`IT.
`
`BACKGROUND
`
`A,
`
`The ’745 Patent
`
`The ’745 patent is titled “Physiological Monitoring Devices, Systems,
`
`and Methods,” and issued on June 23, 2020, from U.S. Patent Application
`
`No. 16/835,772, filed March 31, 2020. Ex. 1001, codes (21), (22), (45),
`
`(54). The ’745 patent summarizesits disclosure as follows:
`
`This disclosure describes embodiments of non-invasive
`methods, devices, and systems for measuring blood constituents,
`analytes, and/or substances such as, by way of non-limiting
`example, oxygen, carboxyhemoglobin, methemoglobin,
`total
`hemoglobin, glucose, proteins,
`lipids, a percentage therefor
`(e.g., saturation), pulse rate, perfusion index, oxygen content,
`total hemoglobin, Oxygen Reserve Index™ (ORI™) or for
`measuring many
`other
`physiologically
`relevant patient
`characteristics. These characteristics can relate to, for example,
`pulse rate, hydration, trending information and analysis, and the
`like.
`
`Id. at 2:40—S0.
`
`Figures 7A and 7B ofthe ’745 patent are reproducedbelow:
`
`
`
`FIG. 7A
`
`FIG. 7B
`
`Figures 7A and 7B abovedepict side and top views, respectively, of a three-
`
`dimensional pulse oximetry sensor according to an embodimentof the 745
`
`patent.
`
`/d. at 5:28-33. Sensor 700 includes emitter 702, light diffuser 704,
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`light block (or blocker) 706, light concentrator 708, and detector 710.
`
`/d.
`
`at 10:49-51. The sensor functionsto irradiate tissue measurementsite 102,
`
`e.g., a patient’s wrist, and detects emitted light that is reflected by the tissue
`
`measurementsite. /d. at 10:43—49. “[L]ight blocker 706 includes an annular
`
`ring having a cover portion 707 sized and shapedto formalight isolation
`
`chamberfor the light concentrator 708 and the detector 710.” /d. at 11:10-
`
`12. “[L]ight blocker 706 and cover 707 ensuresthat the only light detected
`
`by the detector 710 is light that is reflected from the tissue measurement
`
`site.” Id. at 11:16-19.
`
`Figure 8 of the ’745 patent is reproduced below: RIVER
`
`
`
`pee
`
`i NETWORK
`|
`INTERFACE
`
`
`Figure 8 aboveillustrates “a block diagram of an example pulse oximetry
`
`system capable of noninvasively measuring one or more blood analytesin a
`
`monitored patient.” /d. at 5:34—37. Pulse oximetry system 800 includes
`
`sensor 801 (or multiple sensors) coupled to physiological monitor 809.
`
`/d.
`
`at 12:21—23. Sensor 801 includes emitter 804 and detector 806. Jd.
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`at 12:32—34. Monitor 809 includes signal processor 810, which “includes
`
`processing logic that determines measurementsfor desired analytes based on
`
`the signals received from the detector 806.” /d. at 13:33-40. Monitor 809
`
`also includesuser interface 812 that provides “an output, e.g., ona display,
`
`for presentation to a user of pulse oximetry system 800.” /d. at 13:33-35,
`
`13:64-66.
`
`B.
`
`Illustrative Claim
`
`Petitioner challenges claims 2—6, 8, 10—14, 17, 19, and 21—26 of the
`
`°745 patent. Pet. 1. Claims 2-6, 8, and 10-14 depend from claim 1.
`
`Claims 17 and 19 depend from claim 15. Claims 21—26 depend from
`
`claim 20. Claim 3 is illustrative of the claimed subject matter andis
`
`reproduced below,along with claim 1 from whichit depends.
`
`1. A physiological monitoring device comprising:
`a plurality of light-emitting diodes configured to emit light in
`a first shape;
`a material configured to be positioned betweenthe plurality
`of light-emitting diodes and tissue on a wrist of a user
`when the physiological monitoring device 1s in use, the
`material configured to changethe first shape into a second
`shape by which the light emitted from one or more ofthe
`plurality of light-emitting diodes is projected towardsthe
`tissue;
`a plurality of photodiodes configured to detect at least a
`portion ofthe light after the at least the portion of the light
`passes through the tissue, the plurality of photodiodes
`further configured to output at least one signal responsive
`to the detectedlight;
`the surface
`a surface comprising a dark-colored coating,
`configured to be positioned between the plurality of
`photodiodes and the tissue when the physiological
`monitoring device is in use, wherein an opening defined in
`the dark-colored coating is configured to allow at least a
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`portion of light reflected from the tissue to pass through
`the surface;
`a light block configured to prevent at least a portion of the
`light emitted from the plurality of light-emitting diodes
`from reaching the plurality of photodiodes without first
`reachingthe tissue; and
`a processorconfigured to receive and processthe outputted at
`least one signal and determine a physiological parameter
`of the user responsiveto the outputted at least one signal.
`
`Ex. 1001, 15:32-61.
`
`3. The physiological monitoring device of claim 1, further
`comprising a display configured to present a visual feedback
`responsive to the determined physiological parameter.
`Id. at 16:1-3.
`
`C.—Asserted Grounds ofUnpatentability
`
`Petitionerasserts that the Challenged Claims are unpatentable based
`
`on the following grounds:
`
`2, 5,6, 8, 10-12,
`
`Ackermans, Savant, Sarantos’
`
`3, 4, 21-26
`
`13, 14
`
`103
`
`103
`
`Ackermans, Savant, Venkatraman®
`
`3 The Leahy-Smith America Invents Act (“AIA”) included revisions
`to 35 U.S.C. § 103 that became effective on March 16, 2013. Weapply
`the post-AIA version of § 103 here, because the earliest provisional
`application identified in the ’745 patent wasfiled after the effective date of
`the AIA. See Ex. 1001, code (60).
`* WO 211/051888 A2, published May 5, 2011 (Ex. 1011, “Ackermans”).
`> U.S. Patent No. 6,158,245, issued Dec. 12, 2000 (Ex. 1012, “Savant”).
`°U.S. Pat. App. Pub. No. 2014/0275854 A1, published Sept. 18, 2014
`(Ex. 1006, “Venkatraman’’).
`TUS. Patent No. 9,392,946 B1, issued July 19, 2016 (Ex. 1005, “Sarantos’”’).
`
`6
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`Pet. 1-2. Petitioner further relies on the supporting Declaration of Dr. Brian
`
`W.Anthony, dated August 26, 2022. Ex. 1003. Patent Ownerrelies on the
`
`Declaration of R. James Duckworth, dated December 12, 2022. Ex. 2002.
`
`D.
`
`RelatedProceedings
`
`Petitionerfiled three other petitions challenging claims of the
`
`°745 patent in IPR2022-01291, IPR2022-01292, and IPR2022-01465.
`
`Patent Owneridentifies numerousadditional patent applications, patents,
`
`and interpartes review proceedingsas related to the *745 patent. Paper 5,
`
`1—2; Paper 14, 2.
`
`The parties further identify the ’745 patent as a subject of Masimo
`
`Corporation, et al. v. Apple Inc., ITC Inv. No. 337-TA-1276. Pet. 70;
`
`Paper 5,1. Petitioner also states that on December 12, 2022, Patent Owner
`
`asserted the ’745 patent against Petitioner in the U.S. District Court for the
`
`District of Delaware (Case No. 1:22-cv-01378-MN), Paper 13, 1; see also
`
`Paper 14, 1 (identifying the samedistrict court case).
`
`Additionally, the application that issued as the ’745 patent was a
`
`continuation of an application that issued as U.S. Patent No. 10,470,695
`
`(“the 695 patent”). Ex. 1001, code (63). Petitioner states that, through an
`
`interpartes review, the Board found claims6, 14, and 21 of the 695 patent
`
`not patentable “after Patent Ownerdisclaimed the remaining claims of the
`
`’695 Patent following institution of the IPR.” Pet. 71 (citing Apple Inc. v.
`
`Masimo Corp. , 1PR2020-01722, Paper 29 at 2 (PTAB May 5, 2022)).
`
`Patent Ownerfurther identifies Masimo Corporation v. Apple Inc. , Case
`
`No. 22-01895, pending before the U.S. Court ofAppeals for the Federal
`
`Circuit, as an “appeal from final written decision in an interpartes review
`
`proceeding involving a related patent,” and we understand the ’695 patentis
`
`at issue in that appeal. Paper 5, 2-3.
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`I. ANALYSIS
`
`BecausePetitioner has concurrently filed multiple petitions
`
`challenging the same claimsof the samepatent, wefirst consider whether
`
`we should exercise discretion to deny the secondpetition. See 35 U.S.C.
`
`§ 314(a); SAS nst., Inc. v. lancu, 138 S. Ct. 1348, 1356 (2018) (explaining
`
`that section “314(a) invests the Director with discretion on the question
`
`whetherto institute review”); Harmonic Inc. v. Avid Tech., Inc., 815 F.3d
`
`1356, 1367 (Fed. Cir. 2016) (“[T ]he PTO is permitted, but never compelled,
`
`to institute an IPR proceeding.”’). Morespecifically, the Patent Trial and
`
`Appeal Board Consolidated Trial Practice Guide (Nov. 2019) (“CTPG”)®
`
`states that generally “one petition should be sufficient to challenge the
`
`claims of a patent in most situations” and that “multiple petitions by a
`
`petitioner are not necessary in the vast majority of cases.” CTPG 59.
`
`According to the CTPG,“[t]wo or morepetitionsfiled against the same
`
`patent at or about the sametime (e.g., before the first preliminary response
`
`by the patent owner) mayplace a substantial and unnecessary burden on the
`
`Board and the patent ownerand could raise fairness, timing, and efficiency
`
`concerns.” /d. (citing 35 U.S.C. §316(b)). The CTPGalsosets forth the
`
`following guidance:
`
`To aid the Board in determining whether more than one
`petition is necessary, if a petitioner files two or more petitions
`challenging the same patent, then the petitioner should, in its
`petitions or in a separate paperfiled with the petitions, identify:
`(1) a ranking of the petitions in the order in which it wishes the
`Board to consider the merits, if the Board usesits discretion to
`institute any ofthe petitions, and (2) a succinct explanation ofthe
`differences between the petitions, why the issues addressed by
`the differences are material, and why the Board should exercise
`
`8 Available at https://www. uspto.gov/TrialPracticeGuideConsolidated.
`
`8
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`its discretion to institute additional petitions if it identifies one
`petition that satisfies petitioner’s burden under 35 U.S.C.
`§ 314(a).
`
`Id. at 59-60 (footnote omitted).
`
`The Petition and the ’1465 Petition werefiled on the same date and
`
`both seek interpartes review of the sameset of claims of the samepatent.
`
`In the NRP, Petitioner argues that “[m]aterial differences exist between the
`
`petitions,” and that the petitions are “non-redundant”becausetheyrely on
`
`“different combinations of references” applied to “the Challenged Claimsin
`
`materially different ways.” NRP 3. However, we note that Venkatraman
`
`and Sarantosare relied upon byPetitioner in both petitions, indicating some
`
`degree of overlap between the twopetitions.
`
`Petitioner purports to address in the NRP how thepetitions differ, but
`
`merely repeats contentionsset forth in the petitions without substantively
`
`addressing any reasonthe differences are material to our patentability
`
`analysis. According to Petitioner, the references “apply differently” and
`
`“the motivations to combine. .
`
`. materially differ.” /d. at 3.
`
`Lacking from the NRP is any explanation of how the references apply
`
`differently or how the motivations to combine differ to show that two
`
`petitions are warranted. For example, accordingto Petitioner, in the
`
`’1465 Petition Sarantosis asserted and “describes a “wristband-type
`
`wearable fitness monitor’ that measures “physiological parameters,” whereas
`
`in the Petition here it relies on Ackermansas describing “an optical sensor
`
`for measuring the blood oxygenation levels of a user.” /d. at 3. Petitioner
`
`offers no explanation other than that the argumentsare “different” to show
`
`whythe differences are material or why a second petition is warranted.
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`With regard to motivation to combine Venkatraman, wenote that Petitioner
`
`argues in the Petition as follows:
`
`in the art] would have been
`A [person of ordinary skill
`motivated to wirelessly connect the wristband-type physiological
`monitoring device of Ackermans(as previously modified based
`on Savant) to a secondary processing device, such as a
`smartphone, having a user interface with a touch screen display,
`as taught by Venkatraman, in order to increase the functionality
`of the system without significantly increasing the power
`consumption of Ackermans’ sensor.
`
`Pet. 40. Inthe ?1465 Petition, Petitioner argues with regard to motivation to
`
`combine Venkatramanasfollows:
`
`in the art] would have been
`A [person of ordinary skill
`motivated to transmit information from Iwamiya’s[?] wrist-worn
`wearable device, which has limited display space and processing
`power, to a secondary device like a smart phone, as taught by
`Venkatramanin orderto increase the functionality of the system
`without significantly increasing the power consumption of
`Iwamiya’s sensor.
`
`’1465 Petition, 29. Rather than materially differ, as Petitioner asserts, at
`
`least with regard to Venkatraman, the purported motivation to combine
`
`appears to be substantially the samein both petitions.
`
`Petitioner also appears to suggest that two petitions challenging the
`
`same claims of the ’745 patent are warranted in light of the campaign against
`
`it involving “several hundred claims across twenty-twopatents in district
`
`court and ITC proceedings.” NRP 4; see also id. at 5 (arguing that due to
`
`Patent Owner’s “seriallitigation campaign .
`
`.
`
`. institution of both petitionsis
`
`more than justified”’). Petitioner further argues that the references asserted
`
`in the Petition “are highly familiar to the Board” and to Patent Owner,
`
`° U.S. Patent No. 8,670,819 B2, issued Mar. 11, 2014 (Ex. 1004,
`“Twamiya’’).
`
`10
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`because Ackermanswaspreviously asserted by Petitioner in prior
`
`proceedings against Patent Owner.
`
`/d. at5. But Petitioner does not address
`
`why proceedings involving the claims of other patents in other forums
`
`warrant twopetition’s challenging through interpartes review the same
`
`claims of the ’745 patent.
`
`Lastly, according to Petitioner, “[d]ue to word count constraints, two
`
`petitions were needed to address grounds based on the asserted primary
`
`references.” /d. at5. Given the overlap in arguments asserted between the
`
`Petition and the 1465 Petition, including, for example, the rationale for
`
`combining Venkatramandiscussed above, weare not persuadedin this case
`
`that Petitioner had noalternative but to file multiple petitions challenging the
`
`same claims of the same patent merely based on word count constraints
`
`alone. Further, Petitioner advancesin the ?1465 Petition multiple grounds of
`
`unpatentability for nearly every Challenged Claim. See generally’ 1465
`
`Petition. The only Challenged Claim addressed underonly one ground in
`
`the ’1465 Petition is claim 13, where Petitioner relies on Sarantos as
`
`disclosing the additional limitations.
`
`°1465 Petition, 50-52. In the Petition
`
`here, as to claim 13, Petitioner once again relies on Sarantosas disclosing
`
`the additionallimitations, based on substantially the same arguments
`
`Petitioner raises in the ’1465 Petition. Pet. 61-62. Given the overlap in
`
`content between the twopetitions, we find no persuasive support for the
`
`proposition that “word count constraints” required twopetitions.
`
`IV.
`
`CONCLUSION
`
`Wehavereviewedthe Petition and the ?1465 Petition and determine
`
`that, on the record present here, Petitioner has not set forth adequate
`
`reasoning that supports the institution of multiple interpartes reviews based
`
`on twopetitions both directed to claims 2—6, 8, 10—14, 17, 19, and 21-26 of
`
`11
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`the ’745 patent. See generally NRP. Accordingly, in light of our
`
`determinationto institute inferpartes review onall groundspresented in the
`
`’1465 Petition, we exercise discretion under 35 U.S.C. § 314(a) to deny
`
`institution of the Petition in this proceeding.
`
`IV. ORDER
`
`Upon consideration of the record beforeus, tt1s:
`
`ORDEREDthatthe Petition 1s denied and notrial is instituted in this
`
`proceeding.
`
`12
`
`

`

`IPR2022-01466
`Patent 10,687,745 B1
`
`FOR PETITIONER:
`
`Walter Renner
`Dan Smith
`Andrew Patrick
`Nicholas Stephens
`FISH & RICHARDSON P.C.
`Axf-ptab@fr.com
`dsmith@fr.com
`patrick@fr.com
`nstephens@fr.com
`
`FOR PATENT OWNER:
`
`Brian C. Claassen
`Jarom D. Kesler
`Jacob L. Peterson
`Carol Pitzel Cruz
`Daniel Kiang
`KNOBBE, MARTENS, OLSON, & BEAR, LLP
`2bcc@knobbe.com
`2jzk@knobbe.com
`2jup@knobbe.com
`2cmp@knobbe.com
`2dck@knobbe.com
`
`13
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket